Talk:Octreotide

This is the talk page for discussing improvements to the Octreotide article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Octreotide.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

in-Merger of "Octreotide"

I've taken the "Octreotide" article and brought it into this one. I did this for two reasons. First, as a method for clearing a Template:bio-stub. Second, and more importantly, because it provides an immediate context for the drug; as it mimics somatostatin, having it in the context of somatostatin makes sense to me. If you (other editors) do not agree with this, I would ask that you not separate the two concepts unless you are going to add substantially more information to the "Octreotide" article so that it can stand as a non-stub article. Regards, Courtland 01:11, 2005 Mar 12 (UTC) (also repeated on the Somatostatin talk page)

Crystal structure

See Acta Cryst. (1995). D51, 48-59.

There are 237 non-hydrogen atoms with atomic coordinates in this paper - might take a while to enter them in CrystalMaker.

Does anyone have a CIF of this molecule?

Ben (talk) 18:16, 25 January 2009 (UTC)[reply]

Use in Esophageal Varices

Under Off Label and Experimental Uses, Reference 2 is used to support the statement "In patients with suspected esophageal varices, octreotide can be given to help decrease bleeding." The reference, however, does not conclude that octreotide decreases bleeding. It concludes that "The efficacy of terlipressin was not inferior to octreotide..." Korey Pesicka (talk) 18:12, 21 March 2013 (UTC)[reply]

Without critical response to the above comment, I've updated the article by removing the statement along with the reference.Korey Pesicka (talk) 22:12, 30 March 2013 (UTC)[reply]

I've added a new line in place of what you deleted and added a reference. The evidence for the effectiveness of octreotide in treating a variceal bleed might not be great, but it's in every set of guidelines I can find, and it's widely utilised in clinical practice. Pawido (talk) 06:46, 18 August 2013 (UTC)[reply]

more??

Patients with diabetes mellitus might need less insulin or oral antidiabetics when treated with octreotide91.183.159.198 (talk) 17:58, 19 February 2018 (UTC)[reply]